Rivastigmine - RIVASTIGMINE MYLAN PHARMA 4,6 mg/24 heures, dispositif transdermique

Business Listing - December 25, 2019

Rivastigmine RIVASTIGMINE MYLAN PHARMA 4,6 mg/24 heures, dispositif transdermique - N06DA03 MYLAN SAS - 61148412

This is a premium business listing. Stand out from the competition!

List your company and reach more customers today.